Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase

2002 ◽  
Vol 362 (3) ◽  
pp. 619-626 ◽  
Author(s):  
Katsuhiro KITA ◽  
Noriyuki SUEYOSHI ◽  
Nozomu OKINO ◽  
Masanori INAGAKI ◽  
Hideharu ISHIDA ◽  
...  

We have reported previously that the ceramidase from Pseudomonas aeruginosa AN17 isolated from a patient with atopic dermatitis requires detergents for hydrolysis of ceramide (Cer) [Okino, Tani, Imayama and Ito (1998) J. Biol. Chem. 273, 14368–14373]. In the present study, we report that some glycerophospholipids strongly activated the hydrolysis of Cer by Pseudomonas ceramidase in the absence of detergents. Among the glycerophospholipids tested, cardiolipin was most effective in stimulating hydrolysis of Cer followed by phosphatidic acid, phosphatidylethanolamine and phosphatidylglycerol, whereas phosphatidylcholine, lysophosphatidic acid and diacylglycerol were less effective. Interestingly, Staphylococcus aureus-derived lipids, which contain cardiolipin and phosphatidylglycerol as major lipid components, also strongly enhanced the hydrolysis of normal Cer, as well as the human skin-specific ω-hydroxyacyl Cer, by the enzyme in the absence of detergents. It was confirmed that several strains of P. aeruginosa, including AN17, secrete a significant amount of staphylolytic proteases to lyse S. aureus cells, resulting in the release of cardiolipin and phosphatidylglycerol. Since both P. aeruginosa and S. aureus are suspected of being present in microflora of atopic skin, we speculate that S. aureus-derived glycerophospholipids stimulate the hydrolysis of Cer in atopic skin by bacterial ceramidase.

2012 ◽  
Vol 4 (2) ◽  
pp. 523 ◽  
Author(s):  
S. Naz ◽  
M. Iqtedar ◽  
Q. ul Ain ◽  
K. Aftab

With the surprising development across the cosmetic and personal care companies the re-utilization of cosmetic tools is of a common practice. Isolation and detection of human skin pathogens from 100 samples of beauty salon tools i.e., blusher brush, face sponge and wax has been done. All the samples were examined microbiologically for the contamination of Staphylococcus aureus, Pseudomonas aeruginosa, yeast and fungus. It was observed that the percentage of Staphylococcus aureus was higher (100% in sponge, 100% in brush, 88% in wax) in the tools than Pseudomonas aeruginosa (69.6% in sponge, 81.8% in brush and 73.5% in wax), where counts obtained for fungus was 51.5% in sponge, 30.3% in brush and 20.5% in wax. It was observed that the major cause of contamination of saloon tools is repetitive usage on all costumers without considering the hygienic conditions.  Keywords: Human skin pathogens; Cosmetic contamination; Pseudomonas in cosmetics; S.aureus in cosmetics.  © 2012 JSR Publications. ISSN: 2070-0237 (Print); 2070-0245 (Online). All rights reserved.  doi: http://dx.doi.org/10.3329/jsr.v4i2.9640 J. Sci. Res. 4 (2), 523-527 (2012)  


2016 ◽  
Vol 65 (3) ◽  
pp. 253-259 ◽  
Author(s):  
Jacek Międzobrodzki

Staphylococcus aureus colonizes the mucous membrane of the nasal vestibule of a significant number of healthy people. These microorganisms are opportunistic pathogens, that in favorable conditions, may cause infections of various course, location or manifestation. Secondary infections emerge in cases when other risk factors contribute to such a change. One of the diseases during which S. aureus changes its saprophytic character to a pathogenic one is atopic dermatitis (AD), an allergic skin condition of a chronic and recurrent nature. Patients with AD are highly predisposed to secondary staphylococcal infections due to active S. aureus colonization of the stratum corneum, damage of the skin barrier or a defective immune response. Microorganisms present in skin lesions destroy the tissue by secreting enzymes and toxins, and additionally stimulate secondary allergic reactions. The toxins secreted by strains of S. aureus also act as superantigens and penetrate the skin barrier contributing to a chronic inflammation of the atopic skin lesions. The S. aureus species also releases proinflammatory proteins, including enzymes that cause tissue damage. When initiating treatment it is particularly important to properly assess that the onset of the secondary bacterial infection is caused by S. aureus and thus justifying the inclusion of antibiotic therapy. Depending on the severity and extent of the staphylococcal infection, topical antibiotics are used, usually mupirocin or fusidic acid, or general antibiotic treatment is introduced. Another therapeutic strategy without antibiotics has given a positive effect in patients.


2021 ◽  
Vol 78 (4) ◽  
pp. 1267-1276
Author(s):  
Yuzuki Shimamori ◽  
Ajeng K. Pramono ◽  
Tomoe Kitao ◽  
Tohru Suzuki ◽  
Shin-ichi Aizawa ◽  
...  

AbstractThe bacterium Staphylococcus aureus, which colonizes healthy human skin, may cause diseases, such as atopic dermatitis (AD). Treatment for such AD cases involves antibiotic use; however, alternate treatments are preferred owing to the development of antimicrobial resistance. This study aimed to characterize the novel bacteriophage SaGU1 as a potential agent for phage therapy to treat S. aureus infections. SaGU1 that infects S. aureus strains previously isolated from the skin of patients with AD was screened from sewage samples in Gifu, Japan. Its genome was sequenced and analyzed using bioinformatics tools, and the morphology, lytic activity, stability, and host range of the phage were determined. The SaGU1 genome was 140,909 bp with an average GC content of 30.2%. The viral chromosome contained 225 putative protein-coding genes and four tRNA genes, carrying neither toxic nor antibiotic resistance genes. Electron microscopy analysis revealed that SaGU1 belongs to the Myoviridae family. Stability tests showed that SaGU1 was heat-stable under physiological and acidic conditions. Host range testing revealed that SaGU1 can infect a broad range of S. aureus clinical isolates present on the skin of AD patients, whereas it did not kill strains of Staphylococcus epidermidis, which are symbiotic resident bacteria on human skin. Hence, our data suggest that SaGU1 is a potential candidate for developing a phage therapy to treat AD caused by pathogenic S. aureus.


Allergy ◽  
1997 ◽  
Vol 52 (10) ◽  
pp. 1012-1016 ◽  
Author(s):  
M. Sasai-Takedatsu ◽  
T. Kojima ◽  
A. Yamamoto ◽  
K. Hattori ◽  
S. Yoshijima ◽  
...  

Author(s):  
Yuzuki Shimamori ◽  
Ajeng K. Pramono ◽  
Tomoe Kitao ◽  
Tohru Suzuki ◽  
Shin-ichi Aizawa ◽  
...  

AbstractThe bacterium Staphylococcus aureus, which grows on healthy human skin, may cause diseases such as atopic dermatitis (AD). Treatment for such AD cases involves antibiotic use; however, alternate treatments are preferred owing to the development of antimicrobial resistance. This study aimed to characterize the novel bacteriophage SaGU1 as a potential agent for phage therapy to treat S. aureus infections. SaGU1 that infects S. aureus strains previously isolated from the skin of patients with AD was screened from sewage samples in Gifu, Japan. Its genome was sequenced and analyzed using bioinformatics tools, and the morphology, lytic activity, stability, and host range of the phage were determined. The SaGU1 genome consisted of 140,909 bp with an average GC content of 30.2%. The viral chromosome contained putative 225 protein-coding genes and four tRNA genes, carrying neither toxic nor antibiotic resistance genes. Electron microscopy analysis revealed that SaGU1 belongs to the Myoviridae family. Stability tests showed that SaGU1 was heat-stable under physiological and acidic conditions. Host-range testing revealed that SaGU1 could infect a broad range of S. aureus clinical isolates present on the skin of patients with AD, whereas it did not kill strains of Staphylococcus epidermidis, which are symbiotic bacteria in the human skin microbiota. Our data suggest that SaGU1 is a potential candidate for developing a phage therapy to treat AD caused by pathogenic S. aureus.


Sign in / Sign up

Export Citation Format

Share Document